Cost of cervical cancer treatment: Implications for providing coverage to low-income women under the medicaid expansion for cancer care

Women's Health Issues

Volumn 20, Issue 6, 2010, Pages 400-405

  Subramanian, Sujha ^a   Trogdon, Justin ^a   Ekwueme, Donatus U ^b   Gardner, James G ^b   Whitmire, J Timothy ^c   Rao, Chandrika ^c  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NORTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER PREVENTION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; MEDICAID; MEDICARE; TERMINAL CARE; UTERINE CERVIX CANCER;

ADULT; BREAST NEOPLASMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MEDICAID; MIDDLE AGED; NORTH CAROLINA; POVERTY; REGISTRIES; REGRESSION ANALYSIS; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78049510018     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2010.07.002     Document Type: Article

References (28)

1. Bradley C.J., Given C.W., Roberts C. Health care disparities and cervical cancer. American Journal of Public Health 2004, 94:2098-2103.
2. Brown M.L., Riley G.F., Schussler N., Etsioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical Care 2002, 40(8 Suppl). IV-104-117.
3. Buntin M.B., Zaslavsky A.M. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. Journal of Health Economics 2004, 23:525-542.
4. Centers for Disease Control and Prevention (CDC). The National Breast and Cervical Cancer Early Detection Program. Available from: Accessed August 31, 2009. http://www.cdc.gov/cancer/nbccedp/about.htm.
5. Charlson M.E., Pompei P., Ales K.L., Mackenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases 1987, 40:373-383.
6. Chesson H.W., Blandford J.M., Gift T.L., Tao G., Irwin K.L. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspectives on Sexual and Reproductive Health 2004, 36:11-19.
7. Clegg L.X., Li F.P., Hankey B.F., Chu K., Edwards B.K. Cancer survival among US whites and minorities: A SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Archives of Internal Medicine 2002, 162:1985-1993.
8. Collaborative Staging Task Force of the American Joint Committee on Cancer. Collaborative staging manual and coding instructions, version 01.04.00. Jointly published by American Joint Committee on Cancer (Chicago, IL) and U.S. Department of Health and Human Services (Bethesda, MD), 2004. NIH Publication Number 04-5496.
9. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 1992, 45:613-619.
10. French C., True S., McIntyre R., Sciulli M., Maloy K.A. State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: A collaborative effort among government agencies. Public Health Reports 2004, 119:279-285.
11. Garner E.I.O. Cervical cancer disparities in screening, treatment, and survival. Cancer Epidemiology Biomarkers & Prevention 2003, 12:242S-247S.
12. Goldie S.J., Kim J.J., Wright T.C. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstetrics and Gynecology 2004, 103:619-631.
13. Helms L.J., Melnikow J. Determining costs of health care services for cost-effectiveness analyses: The case of cervical cancer prevention and treatment. Medical Care 1999, 37:652-661.
14. Horner M.J., Ries L.A.G., Krapcho M., Neyman N., Aminou R., Howlander N., et al. SEER Cancer Statistics Review, 1975-2006 2009, Available from:, National Cancer Institute, Bethesda, MD, Based on November 2008 SEER data submission, posted to the SEER web site, 2009. http://seer.cancer.gov/csr/1975_2006/.
15. Public Law 106-354. Available from: http://www.cdc.gov/cancer/nbccedp/bccpdfs/publ354-106.pdf.
16. Lantz P.M., Weisman C.S., Itani Z. A disease-specific Medicaid expansion for women: The Breast and Cervical Cancer Prevention and Treatment Act of 2000. Women's Health Issues 2003, 13:79-92.
17. Mandelblatt J.S., Lawrence W.F., Womack S.M., Jacobson D., Yi B., Hwang Y.T., et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002, 287:2372-2381.
18. Manning W.G., Mullahy J. Estimating log models: To transform or not transform?. Journal of Health Economics 2001, 20:461-494.
19. Myers E.R., Mccrory D.C., Subramanian S., Mccall N., Nanda K., Datta S., et al. Setting the target for a better cervical screening test: Characteristics of a cost-effective test for cervical neoplasia screening. Obstetrics and Gynecology 2000, 96:645-652.
20. Owusu G.A., Eve B.E., Cready C.M., Koelln K., Trevino R., Urrutia-Rojas X., et al. Race and ethnic disparities in cervical cancer screening in a safety-net system. Maternal and Child Health Journal 2005, 9:285-295.
21. Ramsey S.D., Zeliadt S.B., Richardson L.C., Pollack L., Linden H., Blough D.K., et al. Disenrollment from Medicaid after recent cancer diagnosis. Medical Care 2008, 46:49-57.
22. Romano P.S., Roos L.L., Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. Journal of Clinical Epidemiology 1993, 46:1075-1079.
23. Saslow D., Runowicz C.D., Solomon D., Moscicki A.B., Smith R.A., Eyre H.J., et al. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA: A Cancer Journal for Clinicians 2002, 52:342-362.
24. Schwartz K.L., Crossley-May H., Vigneau F.D., Borwn K., Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes and Control 2003, 14:761-766.
25. Singh G.K., Miller B.A., Hankey B.F., Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 2004, 101:1051-1055.
26. Warren J.L., Brown M.L., Fay M.P., Schussler N., Potosky A.L., Riley G.F. Costs of treatment for elderly women with early stage breast cancer in fee-for-service settings. Journal of Clinical Oncology 2002, 20:307-316.
27. U.S.Cancer Statistics Working Group United States Cancer Statistics: 1999-2005 Incidence and Mortality Web-based Report 2009, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, Available from:. http://www.cdc.gov/uscs.
28. U.S.Census Bureau Health insurance coverage status and type of coverage by selected characteristics for people in the poverty universe: 2008 Available from:. http://www.census.gov/hhes/www/cpstables/032009/health/h02_001.htm.